Literature DB >> 18643791

Dopamine is necessary to endogenous morphine formation in mammalian brain in vivo.

Carla Neri1, Carla Ghelardini, Bethany Sotak, Richard D Palmiter, Massimo Guarna, George Stefano, Enrica Bianchi.   

Abstract

Morphine, the most used compound among narcotic analgesics, has been shown to be endogenously present in different mammalian/invertebrate normal tissues. In this study, we used mice that cannot make dopamine due to a genetic deletion of tyrosine hydroxylase specifically in dopaminergic neurons, to test the hypothesis that endogenous dopamine is necessary to endogenous morphine formation in vivo in mammalian brain. When dopamine was lacking in brain neurons, endogenous morphine was missing in brain mouse whereas it could be detected in brain from wild type rodent at a picogram range. Our data prove for the first time that endogenous dopamine is necessary to endogenous morphine formation in normal mammalian brain. Morphine synthesis appears to be originated from dopamine through L-tyrosine in normal brain tissue. Morphine synthesis is not considered to occur inside the same neuron in normal tissue; released dopamine might be transported into morphinergic neuron and further transformed into morphine. A physiological role for endogenous morphine is suggested considering that dopamine could modulate thermal threshold through endogenous morphine formation in vivo. Thus, dopamine and endogenous opiates/opioid peptides may be interconnected in the physiological processes; yet, endogenous morphine may represent a basic link of this chain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18643791     DOI: 10.1111/j.1471-4159.2008.05572.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Nitrogen-Containing Constituents of Black Cohosh: Chemistry, Structure Elucidation, and Biological Activities.

Authors:  Dejan Nikolić; David C Lankin; Tamara Cisowska; Shao-Nong Chen; Guido F Pauli; Richard B van Breemen
Journal:  Recent Adv Phytochem       Date:  2015

2.  Abnormal nociception and opiate sensitivity of STOP null mice exhibiting elevated levels of the endogenous alkaloid morphine.

Authors:  Alexandre Charlet; Arnaud H Muller; Alexis Laux; Véronique Kemmel; Annie Schweitzer; Jean-Christophe Deloulme; Denise Stuber; François Delalande; Enrica Bianchi; Alain Van Dorsselaer; Dominique Aunis; Annie Andrieux; Pierrick Poisbeau; Yannick Goumon
Journal:  Mol Pain       Date:  2010-12-20       Impact factor: 3.395

3.  Catechol-O-methyltransferase: potential relationship to idiopathic hypertension.

Authors:  Kirk J Mantione; Richard M Kream; George B Stefano
Journal:  Arch Med Sci       Date:  2010-06-30       Impact factor: 3.318

4.  Biological indications of a novel "short" µ opiate receptor in domestic chicken.

Authors:  Melinda H Sheehan; Richard M Kream; George B Stefano
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

Review 5.  The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication.

Authors:  Mohamed Ouzzine; Sandrine Gulberti; Nick Ramalanjaona; Jacques Magdalou; Sylvie Fournel-Gigleux
Journal:  Front Cell Neurosci       Date:  2014-10-28       Impact factor: 5.505

6.  Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils.

Authors:  Elise Glattard; Ingeborg D Welters; Thomas Lavaux; Arnaud H Muller; Alexis Laux; Dan Zhang; Alexander R Schmidt; François Delalande; Benoît-Joseph Laventie; Sylvie Dirrig-Grosch; Didier A Colin; Alain Van Dorsselaer; Dominique Aunis; Marie-Hélène Metz-Boutigue; Francis Schneider; Yannick Goumon
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

7.  Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Janusz Śmigielski; Dominik Strzelecki
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-15       Impact factor: 2.570

8.  The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-16       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.